Education
About Us
Working with TipRanks
Follow Us
Portfolio #1 - New Portfolio
Portfolio #1
Individual Investor
Ranked #371,837 out of 833,817 TipRanks' Investors
Success Rate
249 out of 682
profitable transactions
profitable transactions
Average Return
36.81%
Average return
per transaction
per transaction
Share this portfolio:
Portfolio Gain
1-Month Return▼ 0.24%
6-Month Return▲ 82.98%
12-Month Return▲ 92.51%
YTD Return▲ 92.93%
Total Return▲ 424.11%
Best Trade
Bio
General portfolio. I have a private one which I am more active in
Performance
19.30%0-19.30%
▲ 11.63%
▲ 6.28%
▲ 4.90%
May 2025
▲ 9.25%
▲ 5.14%
▲ 6.05%
Jun 2025
▲ 7.60%
▲ 2.30%
▲ 11.88%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 19.30%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 7.91%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 7.92%
Oct 2025
▼ 3.57%
▲ 0.19%
▲ 12.84%
Nov 2025
▲ 1.45%
▲ 1.32%
▲ 4.28%
Dec 2025
▲ 11.63%▲ 6.28%▲ 4.90%
▲ 9.25%▲ 5.14%▲ 6.05%
▲ 7.60%▲ 2.30%▲ 11.88%
▲ 2.76%▲ 2.05%▲ 19.30%
▲ 12.88%▲ 3.56%▲ 7.91%
▲ 10.96%▲ 2.38%▲ 7.92%
▼ 3.57%▲ 0.19%▲ 12.84%
▲ 1.45%▲ 1.32%▲ 4.28%
Recent Activity
Sagimet Biosciences, Inc. Class A
0%
0.00%
1
Open
Dec 25, 2025
Integral Ad Science
―
▲ 8.84%
2
Close
Dec 24, 2025
Avidia Bancorp, Inc.
0%
0.00%
1
Open
Dec 24, 2025
Anterix
0%
0.00%
1
Open
Dec 24, 2025
Relmada Therapeutics
0%
▲ 2.45%
1
Open
Dec 23, 2025
Clover Health Investments
0%
▼ 2.69%
1
Open
Dec 22, 2025
Processa Pharmaceuticals
0%
▼ 10.00%
1
Open
Dec 18, 2025
Avalo Therapeutics
0%
0.00%
1
Open
Dec 18, 2025
Milestone Pharmaceuticals
0%
▼ 5.91%
1
Open
Dec 16, 2025
NexGel Inc
0%
▼ 3.05%
1
Open
Dec 16, 2025
AC Immune SA
0%
▼ 4.86%
1
Open
Dec 16, 2025
CASI Pharmaceuticals
0%
▼ 11.14%
1
Open
Dec 16, 2025
Agape ATP
0%
▲ 22.22%
1
Open
Dec 16, 2025
Contineum Therapeutics, Inc. Class A
0%
▲ 9.78%
1
Open
Dec 16, 2025
Enliven Therapeutics
0%
▼ 1.06%
1
Open
Dec 16, 2025
EyePoint Pharmaceuticals
0%
▼ 16.62%
3
Open
Dec 15, 2025
Tenaya Therapeutics
0%
▼ 6.52%
1
Open
Dec 15, 2025
Legend Biotech
0%
▲ 4.41%
1
Open
Dec 15, 2025
Aardvark Therapeutics, Inc.
0%
▼ 1.45%
1
Open
Dec 15, 2025
Ascendis Pharma
0%
▼ 0.20%
1
Open
Dec 15, 2025